Checkpoint Therapeutics, Inc. (CKPT): Price and Financial Metrics

Checkpoint Therapeutics, Inc. (CKPT): $3.31

0.15 (-4.34%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

D

CKPT Price/Volume Stats

Current price $3.31 52-week high $4.50
Prev. close $3.46 52-week low $1.38
Day low $3.21 Volume 732,900
Day high $3.39 Avg. volume 866,083
50-day MA $3.41 Dividend yield N/A
200-day MA $2.69 Market Cap 161.64M

CKPT Stock Price Chart Interactive Chart >


Checkpoint Therapeutics, Inc. (CKPT) Company Bio


Checkpoint Therapeutics, Inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of non-chemotherapy and immune-enhanced combination treatments for patients with solid tumor cancers. The company was founded in 2014 and is based in New York, New York. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.


CKPT Latest News Stream


Event/Time News Detail
Loading, please wait...

CKPT Latest Social Stream


Loading social stream, please wait...

View Full CKPT Social Stream

CKPT Price Returns

1-mo 4.09%
3-mo -2.07%
6-mo 43.91%
1-year N/A
3-year -83.11%
5-year -85.61%
YTD 3.44%
2024 39.74%
2023 -55.19%
2022 -83.57%
2021 17.36%
2020 54.07%

Continue Researching CKPT

Here are a few links from around the web to help you further your research on Checkpoint Therapeutics Inc's stock as an investment opportunity:

Checkpoint Therapeutics Inc (CKPT) Stock Price | Nasdaq
Checkpoint Therapeutics Inc (CKPT) Stock Quote, History and News - Yahoo Finance
Checkpoint Therapeutics Inc (CKPT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!